Global Oncology Academy

Improving Surveillance for Colorectal Cancer in IBD Patients

ReachMD Healthcare Image
RestartResume

Dr. Francis Farraye discusses the importance of colorectal cancer screening in IBD patients.

  • Overview

    Studies have shown that certain patients living with inflammatory bowel disease, or IBD, have a higher risk of developing colorectal cancer. In fact, IBD ranks as the third highest risk factor for the development of colorectal cancer.

    Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. Francis Farraye, gastroenterologist and Professor of Medicine and Co-Director of the Center for Digestive Disorders at Boston University School of Medicine. The two talk about making guidelines on endoscopic screening, surveillance, and detection of dysplasia more beneficial to IBD patients.

  • Publication Date

    Release Date: 03/06/2017

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free